The short version of HGF/c-Met fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-06-14. Anything still debated is marked as such rather than presented as settled.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide analog | Structural features include amino acid residues and a hexanoic acid group. |
| Common synonyms | PNB-0408; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Names vary by source and should be verified. |
| Origin | Angiotensin IV research | Developed as a modified analog in academic laboratories. |
| Primary research focus | Synaptic growth and cognition | Studied mainly in cultured neurons and rodent models. |
| Regulatory status | Not approved as a drug | No accepted human therapeutic or supplement status. |
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The chemical structure of penicillin was first suggested by Abraham in 1942. Dorothy Hodgkin determined the correct chemical structure of penicillin using X-ray crystallography at Oxford in 1945. In 1945, the US Committee on Medical Research and the British Medical Research Council jointly published in Science chemical analyses conducted at different universities, pharmaceutical companies and government research departments. The report announced the existence of different forms of penicillin compounds which all shared the same structural component called β-lactam. The penicillins were designated by Roman numerals in UK (penicillin I, II, III and IV) in order of their discoveries, and known by letters (F, G, X, and K) referring to their origins or sources in the US, as below:
Although scientifically obsolete because it does not meet the definition of a complementary color in which a neutral or black color must be mixed, it is still a model used in artistic environments, causing confusion about primary and complementary colors. It can be considered an approximation of the CMY color model. The RYB color model relates specifically to color in the form of paint and pigment application in art and design. Other common color models include the light model (RGB) and the paint, pigment and ink CMY color model, which is much more accurate in terms of color gamut and intensity compared to the traditional RYB color model, the latter emerging in conjunction with the CMYK color model in the printing industry.
In addition to this, the Dayak community in Sarawak celebrate a harvest festival known as Gawai, and the Kadazandusun community celebrate Kaamatan. Despite most festivals being identified with a particular ethnic or religious group, celebrations are universal. In a custom known as "open house" Malaysians participate in the celebrations of others, often visiting the houses of those who identify with the festival.
Sources: en.wikipedia.org
April 8: Decree protecting wives of political emigrants, but not husbands of female emigrants. August 31: Decree adjusting penalties for pregnant women sentenced to the pillory. September 20: Law on civil status registration and divorce, establishing near equality between spouses. Minimum marriage age set at 13 for girls and 15 for boys. 1793
=== Other characters === Lonnie Anderson (Josh C. Williams, Luke Edwards, Kristopher Kent Hill) – Crystal's eldest child, born to her deceased husband, Sonny. Art (Dan Butler) – A divorced accountant to whom Roseanne and Jackie sell a motorcycle, and who provides tax services to Lanford Custom Cycle. Bob (John McConnell) – A close friend of Dan's. Dwight (William Sadler) – A buddy of Dan's who appears in the early seasons of Roseanne, who had a crush on Jackie. In The Conners, there is another character named Dwight who Dan appears to be friends with, but the character is not portrayed by William Sadler and might be a different character altogether. Fisher (Matt Roth) – Jackie's former long-time boyfriend, whom Dan ultimately went to jail for assaulting after learning he abused Jackie. Stacey Flagler (Traci Lords) – A waitress at the Lunchbox. George (Joseph Gordon-Levitt) – D.J.'s classmate. Gary Hall (Brian Kerwin) – Jackie's former fiancé. Heather (Heather Matarazzo) – D.J.'s girlfriend. Jimmy Meltrigger (Stephen Dorff) – Becky's former boyfriend from high school. Chip Lang (Jared Rushton) – Becky's former boyfriend from high school. Marla (Morgan Fairchild) – Nancy's girlfriend. Anne-Marie Mitchell (Adilah Barnes) – Roseanne's childhood friend, who is married to one of Dan's poker buddies, Chuckie. She and Chuck have a son, Chuck Jr., who is the same age as Lonnie and Darlene. Chuckie Mitchell (James Pickens Jr.) – Anne-Marie's husband, who occasionally worked with Dan.
The American kestrel is likely the most abundant falcon in North America, although its total population is difficult to quantify, as local populations can change quickly due to resource availability. Count data from the USGS Breeding Bird Survey (BBS) indicate that the North American breeding population is experiencing long-term and gradual but sustained declines, with some regions, such as New England and coastal California, exhibiting more rapid declines. Count data from raptor migration corridors also indicate regional population declines and largely corroborate BBS data. The North American population has been estimated at 1.2 million pairs, with the Central and South American populations being as large. A smaller estimate is 236,000 birds wintering in North America. A population increase occurred in the 18th and 19th centuries, probably due to deforestation for agriculture. The resulting pastures provided an ideal habitat for kestrels. As of its 2025 IUCN assessment, the global population of American kestrels is estimated to be 9.2 million mature individuals. The southeastern U.S. subspecies (Falco sparverius paulus) has declined 82% since 1940 due to a decrease in nest site availability. This decline is a result of longleaf pines being cleared for agricultural fields. Despite this, the American kestrel is classed as least concern on the IUCN Red List. The Peregrine Fund, a leading non-profit organization advancing research and conservation of birds of prey worldwide, launched the American Kestrel Partnership in 2012.
=== Switzerland === In the Romandy, a moitié-moitié (lit. half-half) can refer to coffee mixed with an equal amount of milk.. In the German-speaking part of Switzerland, especially in the north-eastern part, a mixture of apple and orange juice is known as "halb halb" ("half half", sometimes written 1+1).
Sources: en.wikipedia.org
The addition of S. boulardii to standard triple therapy for the eradication of Helicobacter pylori infection has been associated with a modest but statistically significant increase in eradication rates in a meta-analysis. The same analysis also reported a significant reduction in common adverse effects of eradication therapy, including diarrhea and nausea.
=== Trade === Crude oil is traded as a future on both the NYMEX and ICE exchanges. Futures contracts are agreements in which buyers and sellers agree to purchase and deliver specific amounts of physical crude oil on a given date in the future. A contract covers any multiple of 1,000 barrels and can be purchased up to nine years into the future.
The only CK1 in Plasmodium, PfCK1 (PF3D7_1136500), presents 69% of identity with human CK1 within the kinase domain and is essential for completion of the asexual intra-erythrocytic cycle. Similar to other CK1s, also PfCK1 has multiple binding partners and thus potentially regulates multiple pathways, including those regulating transcription, translation, and protein trafficking. Finally, PfCK1 seems to be essential for parasite proliferation in erythrocytes. From the six CK1 paralogues in Leishmania donovani only two paralogs, LdBPK_351020.1 and LdBPK_351030.1 (LmCK1.2), are closely related to human CK1. The only paralog described as having a function in the host cell. LdBPK_351030.1 is active in both promastigotes and amastigotes. LmCK1.2 can be inhibited by the CK1-specific inhibitor D4476 and is important for intracellular parasite survival. So far, only few substrates for LmCK1.2 have been identified and the functions of LmCK1.2 in the parasite are poorly studied. Although LmCK1.2 is highly identic to human CK1, several small molecules have been identified to specifically target Leishmania CK1, thereby providing opportunities for new therapeutic strategies.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide-like compound studied primarily in preclinical models. It is often classified as an angiotensin IV analog and has been investigated for effects on neuronal connectivity. It is not an approved drug or dietary supplement.
The exact mechanism is uncertain. Some research proposes activation of hepatocyte growth factor/c-Met signaling, while other evidence implicates insulin-regulated aminopeptidase. Multiple pathways may contribute, depending on the experimental system.
Published large-scale human trials are lacking. Most available data come from cell cultures and animal studies. As a result, human safety, appropriate dosing, and clinical effectiveness are not established.
Dihexa is a synthetic peptidomimetic related to angiotensin IV. It is studied in preclinical research for effects on synaptic signaling and cognition. It is not an approved medication.